Advertisement

Author: Alan Condon

Advertisement

From a revived lawsuit against a prominent commercial payer to a patent infringement case and a tainted spine product that may have gotten a patient sick, here are three spine cases that made headlines in the past month:

While CMS' decision last year to gradually phase out the inpatient-only list has been widely welcomed by the spine community, other regulatory changes related to reduced reimbursement and increased prior authorization requirements have not.

Advertisement